Neurocrine Bioscience buy StockNews.com
Start price
15.07.23
/
50%
€85.20
Target price
15.07.24
-
Performance (%)
51.94%
Price
21.05.24
€129.45
Summary
This prediction is currently active. With a performance of 51.94% the BUY prediction by StockNews_com is a big success. This prediction currently runs until 15.07.24. The prediction end date can be changed by StockNews_com at any time. StockNews_com has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Neurocrine Bioscience | 1.172% | 1.172% |
iShares Core DAX® | -0.268% | 5.471% |
iShares Nasdaq 100 | 1.854% | 7.851% |
iShares Nikkei 225® | 0.284% | 1.729% |
iShares S&P 500 | 1.178% | 5.269% |
Comments by StockNews_com for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
Ratings data for NBIX provided by MarketBeat
Stopped prediction by StockNews_com for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€107.85
23.09.23
23.09.23
-
23.09.24
23.09.24
20.03%
21.05.24
21.05.24